Longitudinal Analysis of B cell Remodeling in Systemic Lupus Erythematosus Following iPSC-derived CAR T-cell Therapy
Tuesday, October 28, 2025 1 min read
Key Takeaway: The article discusses the longitudinal analysis of B cell remodeling in patients with systemic lupus erythematosus (SLE) following treatment with iPSC-derived CAR T-cell therapy. It highlights the importance of understanding the immune response in SLE and the potential implications for future therapies. However, specific results or findings from the analysis are not provided.
Price reaction · baseline $1.55 (2025-10-27 close) · hit pre-market · clean, no other FATE news in the window
day 0 close · peak
-3.9%
Market Sentiment Analysis
Full Press Release Details
• Privacy Overview
• Strictly Necessary Cookies
• 3rd Party Cookies
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
For more information about the data we collect please visit our Privacy Policy .
Strictly Necessary Cookies is enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.